Inventor · disambiguated record
Steven M. Dubinett
Also filed as: DUBINETT STEVEN · DUBINETT STEVEN M
7 granted patents·11 pending applications·13 citations·filing 2002–2022
78Inventor score
Top patents by PatentIndex Score
18 records- 0185US8920807B2Vault complexes for cytokine deliveryROME LEONARD H·Filed 2010·Granted Dec 30, 2014·10 cites·17 claims
- 0273US11499196B2Cell-free DNA methylation patterns for disease and condition analysisUNIV CALIFORNIA·Filed 2017·Granted Nov 15, 2022·2 cites·31 claims
- 0372US11793860B2Vault complexes for cytokine deliveryUNIV CALIFORNIA·Filed 2020·Granted Oct 24, 2023·0 cites·14 claims
- 0469US11236139B2Combination immunotherapyUNIV CALIFORNIA·Filed 2015·Granted Feb 1, 2022·1 cites·9 claims
- 0564US10780147B2Vault complexes for cytokine deliveryUNIV CALIFORNIA·Filed 2017·Granted Sep 22, 2020·0 cites·12 claims
- 0662US9597372B2Vault complexes for cytokine deliveryUNIV CALIFORNIA·Filed 2014·Granted Mar 21, 2017·0 cites·12 claims
- 0760US2023167507A1Cell-free dna methylation patterns for disease and condition analysisUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0860US2022162279A1Combination immunotherapyUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0957US10166277B2Vault immunotherapyUNIV CALIFORNIA·Filed 2016·Granted Jan 1, 2019·0 cites·41 claims
- 1057US2004175355A1Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammalsUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 1155US2015150821A1Vault ImmunotherapyUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 1251US2022280609A1Combination cancer therapy agents and methodsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1350US2024197928A1Sodium-dependent glucose transporter 2 as a diagnostic and therapeutic target for pre-malignant lesionsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1448US2016058837A1Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammalsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 1546US2022177534A1Ccl21 and checkpoint inhibitors for the treatment of cancerUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1643US2003175801A1Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammalsFiled 2002·Application pending·0 cites
- 1736US2012315641A1Protein Markers for Lung Cancer Detection and Methods of Using ThereofDUBINETT STEVEN M·Filed 2011·Application pending·0 cites
- 1830US2015323539A1Blood markers for lung cancer predispositionUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven M. Dubinett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →